LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study

Donato Alarcón-Segovia, James A. Tumlin, Richard A. Furie, James D. McKay, Mario H. Cardiel, Vibeke Strand, Robert G. Bagin, Matthew D. Linnik, Bonnie Hepburn, Jacob Aelion, Gerald B. Appel, Cynthia Aranow, Stanley Ballou, Michael Becker, Nancy J. Becker, H. Michael Belmont, Jill P. Buyon, Anthony Bohan, William G. Brelsford, Nancy L. CarteronMary E. Cronin, Raphael J. DeHoratius, Luis R. Espinoza, Mark C. Genovese, Gary Gilkeson, Antonio Gil-Aguado, Oscar Gluck, Jose L. Granda, Maria Hill, Paul Howard, Miguel Ingelmo, Kenneth C. Kalunian, Gary M. Kammer, Keith Kanik, Stanley Kaplan, Howard M. Kenney, Neil A. Kurtzman, Robert G. Lahita, Michael R. Liebling, Jill Suzanne Lindberg, Susan Manzi, Joan T. Merrill, Larry W. Moreland, C. Michael Neuwelt, Michelle A. Petri, Rosalind Ramsey-Goldman, Steven G. Rosenblatt, Naomi Rothfield, John T. Schousboe, K. Lea Sewell, Yvonne Sherrer, Douglas B. Smith, Bruce S. Spinowitz, Roland M. Staub, Steven Stern, Jon T. Stevenson, Ronald Van Vollenhoven, John Varga, Miguel Vilardell-Tarres, Daniel J. Wallace

Research output: Contribution to journalArticlepeer-review

244 Scopus citations

Fingerprint Dive into the research topics of 'LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences